Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04084561 · ClinicalTrials.gov registry record · NA
Risk Communication in African American Smokers
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT04084561: Completed NA study, sponsored by Temple University.
NCT04084561 is a NA study that has completed, run by Temple University. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04084561, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Participants will be given hypothetical personalized genetic risk results and ask to think about how they might respond to such information if they actually received such results.
Primary Outcome
use self report 7 item (condition options) MTSS (Motivation to Stop Smoking) Scale with yes/no option to determine the quitting intention condition; range of scale : 1-7, with higher score means higher motivation to quit smoking
Interventions
- BEHAVIORAL HRHA
- BEHAVIORAL LRLA
- BEHAVIORAL HRLA
- BEHAVIORAL LRHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
What the finished NCT04084561 record still lists
NCT04084561 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which HRHA is the first listed.
NCT04084561 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04084561 about?
NCT04084561 is a clinical study titled "Risk Communication in African American Smokers". The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Participants will be given hypothetical personalized genetic risk results and ask to think about how they might respond to such information if they actually received such...
What is the current status of trial NCT04084561?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2018-09-01. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT04084561?
The interventions under investigation include: HRHA (BEHAVIORAL), LRLA (BEHAVIORAL), HRLA (BEHAVIORAL), LRHA (BEHAVIORAL).
Who is sponsoring clinical trial NCT04084561?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04084561's enrollment target sits among peer trials
166 625th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI